New Study Reveals Generic Drugs Continue Entering Market as Competition from Authorized Generics Increases
U.S. Newswire, April, 2007
To: HEALTH/MEDICAL EDITORS
Contact: Jennifer Page of PhRMA, 1-202-835-3460
WASHINGTON, April 19 /PRNewswire-USNewswire/ -- According to a new study by researchers at the Massachusetts Institute of Technology's (MIT) School of Management and Analysis Group Inc., there is no evidence that the recent increase in prevalence of authorized generics has resulted in delays in generic entry into the marketplace. This report reinforces findings in a separate study that authorized generics increase competition and lower prices for consumers.
"This study and others show that authorized generics are increasing competition and helping lower prescription drug prices for patients, not harming competition," said Lori Reilly, PhRMA's vice president for policy and research. "As a...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- LIFO vs. FIFO: a return to the basics
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
